Current location:health >>
Why Amylyx is pulling ALS drug Relyvrio from US market after study
health438People have gathered around
IntroductionWASHINGTON (AP) — The maker of a drug for Lou Gehrig’s disease that recently failed in a large study ...
WASHINGTON (AP) — The maker of a drug for Lou Gehrig’s disease that recently failed in a large study said Thursday it will pull the medicine from the market, acknowledging it didn’t help patients with the deadly neurological condition.
Amylyx Pharmaceuticals announced it will voluntarily halt sales and marketing of the drug in the U.S. and Canada, where new patients will no longer be able to get a prescription.
“While this is a difficult moment for the ALS community, we reached this path forward in partnership with the stakeholders who will be impacted and in line with our steadfast commitment to people living with ALS,” company co-founders said in a statement. Patients already taking the therapy who wish to continue will be able to enroll in a program to receive it for free.
The Food and Drug Administration approved the much-debated drug, Relyvrio, in September 2022, following a years-long advocacy campaign by patients with amyotrophic lateral sclerosis, or ALS.
Tags:
Reprint:Friends are welcome to share on the Internet, but please indicate the source of the article when reprinting it.“International Iterations news portal”。http://sweden.chongwenmenhotelbeijing.com/content-14c599941.html
Related articles
Saudi Arabia is going to sponsor the WTA women's tennis rankings under a new partnership
healthNEW YORK (AP) — Saudi Arabia’s move into tennis will now include a multiyear deal to sponsor the WTA ...
【health】
Read moreVOX POPULI: Leadership skills of the past are missing in the politics of today
healthU.S. economist Joseph Dodge (1890-1964) arrived in occupied Japan in 1949 as the financial adviser t ...
【health】
Read moreChina News Jack Ma: Alibaba's founder turns up in Japan as college professor
healthYour web browser is no longer supported. To improve your experience update it here ...
【health】
Read more
Popular articles
- Young Boys seals 6th Swiss soccer league title in 7 years after rallying from firing coach Wicky
- It's about to get more difficult for Americans to visit Brazil
- Artificial intelligence found to be 'superior to biological intelligence'
- One dead in Northland crash
- OpenAI pauses ChatGPT voice after Scarlett Johansson comparisons
- VOX POPULI: Celebrating the arrival of spring the same way as in ‘Tale of Genji’
Latest articles
Elon Musk gets approval from FDA to implant his Neuralink brain chip into a second patient
Hong Kong lawmaker's petition opposing Gay Games is prejudiced, activist says
Latest review should 'put to bed' methane debate, minister says
'Barbie' makes history with $1 billion at the box office
The Latest
Winston Peters discusses Gaza ceasefire with UN Secretary
LINKS
- Hoda Kotb, 59, reveals she is STILL single and 'looking for the one'
- Zoe Saldana and husband Marco Perego look stylish in classic all
- Influencer, 22, left with second
- Chinese vice premier stresses timely delivery of homes to buyers
- Tori Spelling, 50, brags she has the 'lady parts of a 14
- Rachel Zegler and Kit Connor are confirmed to make Broadway debuts in Romeo + Juliet
- Vogue Williams debuts her new cropped hairdo
- Security corridor shields Türkiye from terrorism: president
- Sami Sheen is nearly unrecognizable at Coachella as she swaps her racy OnlyFans look for a covered
- Tori Spelling, 50, brags she has the 'lady parts of a 14